Draft Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2019 Draft Quality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019 Draft Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019

Maria Eagle Excerpts

Wednesday 19th December 2018 General Committees

[Maria Eagle (Garston and Halewood) (Lab)]

May I say what a pleasure it is to be here this morning serving under your chairmanship, Mr Stringer? I concur with the questions and remarks of my hon. Friend the Member for Washington and Sunderland West, and with the question from the hon. Member for Linlithgow and East Falkirk.

I have one or two questions for the Minister about some of what I have seen in the draft regulations and the explanatory memorandum. She rightly says that only a small number of organs are shared between EU and non-EU countries, with fewer than 30 organs imported or exported on average. However, the draft regulations will come into force in a no-deal scenario, in which there will be no transition period and all the borders will go up. Only a small number of organs might come and go, but they are vital; many are a matter of life and death for the individual who will receive them. What arrangements has her Department made to make sure that those organs can get through?

The Government’s own preparedness documents suggest that there are going to be queues at borders. It is very easy to see how this kind of time-critical matter could get caught up in bureaucracy at borders. I know that the regulations are just about making arrangements, but I did not find anything in the Minister’s remarks or the explanatory memorandum to say what contingency arrangements the Government were making to ensure that the organs get through. That time-critical matter is often one of life and death. I would be grateful if the Minister said something about that.

There is no impact assessment because the Government have taken the view that the financial impact is lower than the £5 million threshold for which such documents are prepared. It would be helpful to have some idea of the extra cost that the arrangements provided for by these instruments would impose on the authorities that take on the job currently done by the Commission. Do the Government intend to reimburse them the extra money that that will cost? A six-month period is provided in the instruments for the new administrative arrangements, if necessary, to be made, but there is no reference—and the Minister did not make one—to whether the Government intend to reimburse those authorities for the extra work.

A small number of organisations import and export human tissue and organs, but I do not know how many there are. Can the Minister tell us and have the Government been talking in detail with them about precisely what they will need to do? There is the six-month period, but what precisely will those organisations have to do? I would be grateful for a little more detail from the Minister before we take a view on these instruments.

Dangerous Waste and Body Parts Disposal: NHS

Maria Eagle Excerpts

Tuesday 9th October 2018 Commons Chamber

[Stephen Barclay]

The key issue for performance under the contracts is what, contractually, the legal requirements on HES are and whether those contractual terms have been breached. Part of the lessons learned is to look at whether contractual enforcement powers are sufficient. In terms of moving forward in respect of the other HES sites, that will depend on the contracts that the supplier has and whether it is in breach of those contracts or of enforcement action from the Environment Agency. To date, the Environment Agency has served one partial suspension, on the Normanton site. As I referred to, the Environment Agency was at the other site over the weekend. This is an area of significant scrutiny, but it will be for the Environment Agency to determine whether the company is not in compliance with its permits.

[Maria Eagle (Garston and Halewood) (Lab)]

So far, the Minister appears to have been far more interested in contractual arrangements than in public accountability. Can he explain how come Cobra has met and this House has not been informed of it? This House should be informed about Cobra meetings as soon as possible after they are finished.

[Stephen Barclay]

I am not sure about the exact protocols for when Cobra should and should not be reported, but given that it usually deals with highly confidential matters, I would have thought that not every issue should necessarily be reported in the first instance. We have been focused not on contractual niceties, but on ensuring that the NHS continues to deliver first-class services. As I referred to earlier, this is the first opportunity we have had following the conference recess to notify the House, following the contractual arrangements being made.

Medicines and Medical Devices Safety Review

Maria Eagle Excerpts

Wednesday 21st February 2018 Commons Chamber

[Mr Hunt]

I can give my hon. Friend the assurance for which he has asked. We have announced today that we are improving the system of alerting both general practices and community pharmacies to ensure that the right advice is given and the right safeguards are in place, so that people who are pregnant or might become pregnant do not take a medicine that is very powerful and very effective in the right circumstances, but incredibly dangerous in the wrong ones.

[Maria Eagle (Garston and Halewood) (Lab)]

I welcome the Secretary of State’s intention to look further at these very concerning issues, but I fear that his putting them all in one place means that he may not be giving sufficient attention to the Primodos issue, which is a scandal of very many years’ standing. I do not think that the recent report of the expert working group is the basis on which Baroness Cumberlege or anyone else should look further at the matter, because it was a complete whitewash, and the Secretary of State needs to acknowledge that. I think that if he were to do so, the people affected by Primodos over the last 40 years or more would feel much more confident that the process that he has described today might enable them to secure some resolution.

[Mr Hunt]

I understand why the hon. Lady has asked her question in the way that she has, but we set up the expert working group after a lot of very careful thought because we honestly wanted an answer. We are faced with circumstances in which scientists disagree, and in those circumstances it would not be right for me, as Secretary of State, to announce a different scientific view. I think that the right thing to do is to allow someone the time and space in which to look at the issues that the hon. Lady has raised, and that is what Baroness Cumberlege will do.

Adult Social Care Funding

Maria Eagle Excerpts

Thursday 6th July 2017 Commons Chamber

[Steve Brine]

That is exactly why I said that this has to be a one-system solution. We need the NHS to work on delayed transfers of care, but we need local authorities to work with us as well, which is what the better care fund is all about. We know that it is better for people to be cared for in their own home, but that is not always possible, which is why we need a long-term solution to the funding of adult social care that deals with not only residential but domiciliary, care—and that is why we tried to introduce that debate during the election.

[Maria Eagle (Garston and Halewood) (Lab)]

Liverpool City Council spends more on adult social care than it is able to raise in council tax, yet still has more of a cut to make, and pays a very low level of fees as a consequence. Can the Minister give an assurance that councils such as Liverpool will not be further disadvantaged when he rolls out the extra funding he is promising to try to improve this situation?

[Steve Brine]

As I said, councils have access to a total of just over £9.25 billion more in dedicated funding for social care over the next three years as a result of measures introduced by this Government since 2015. That is enough to increase social care spending in real terms. And let me just put this on the record for the House: the UK spends more as a share of GDP on long-term care than other industrialised countries, including much-vaunted Germany, Canada and the United States.